0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Diagnosis of Yersinia enterocolitica Infection in Cancer Patients With Diarrhea in the Era of Molecular Diagnostics for Gastrointestinal Infections

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Yersinia enterocolitica is an uncommon cause of diarrhea, mesenteric adenitis and bacteremia in the United States. There is limited information regarding the clinical course in immunocompromised patients. We describe the clinical presentations and outcomes in patients with cancer with Y. enterocolitica diagnosed at a US cancer center before and after introduction of gastrointestinal multiplex panel (GIMP) nucleic acid amplification tests (NAATs).

          Methods

          We reviewed medical records of all patients with Y. enterocolitica isolated from cultures or identified by means of NAATs from 2000 to 2018. We then extracted demographic information, clinical characteristics, treatment, and overall mortality rate at 30 days after the diagnosis of yersiniosis.

          Results

          We identified 17 cases: 6 cases by culture before April 2016 and 11 cases by NAATs after that; 4 of the latter were confirmed by means of culture (36%). This represented an 8-fold increase for overall detection and a 3-fold increase in culture-proved infections when adjusted per 1000 admissions. The most common presenting symptom was diarrhea (11 of 14 [79%]), followed by abdominal pain (9 of 14 [64%]) and nausea and vomiting (6 of 14 [43%]). In 1 patient, the infection resolved spontaneously; the other patients received antibiotic treatment, the majority with a fluoroquinolone. The 30-day mortality rate was 7.1%, and the cause of death was a complication of advanced cancer.

          Conclusion

          Since implementing use of the GIMP, we observed an increase in Y. enterocolitica cases, possibly related to increasing number of patients with cancer at our institution who are receiving intensive immunosuppression, increased testing due to ease and availability, and increased sensitivity of NAATs. GIMP NAATs are redefining the epidemiology of Y. enterocolitica infection in patients with cancer.

          Abstract

          Since implementing use of the gastrointestinal multiplex panel (GIMP), we observed an increase in Yersinia enterocolitica infections, possibly related to the increase in patients with cancer receiving intensive immunosuppression, increased testing due to availability, and increased GIMP sensitivity.

          Related collections

          Most cited references9

          • Record: found
          • Abstract: found
          • Article: not found

          Yersinia enterocolitica: the charisma continues.

          Yersinia enterocolitica, a gram-negative coccobacillus, comprises a heterogeneous group of bacterial strains recovered from animal and environmental reservoirs. The majority of human pathogenic strains are found among distinct serogroups (e.g. O:3, O:5,27, O:8, O:9) and contain both chromosome- and plasmid (60 to 75 kb)-mediated virulence factors that are absent in "avirulent" strains. While Y. enterocolitica is primarily a gastrointestinal tract pathogen, it may produce extraintestinal infections in hosts with underlying predisposing factors. Postinfection sequelae include arthritis and erythema nodosum, which are seen mainly in Europe among patients with serogroups O:3 and O:9 infection and HLA-B27 antigen. Y. enterocolitica is acquired through the oral route and is epidemiologically linked to porcine sources. Bacteremia is prominent in the setting of immunosuppression or in patients with iron overload or those being treated with desferrioxamine. metastatic foci following bacteremia are common and often involve the liver and spleen. Of particular concern is blood transfusion-related bacteremia. Evidence has accumulated substantiating the role of Y. enterocolitica as a food-borne pathogen that has caused six major outbreaks in the United States. The diagnosis of Y. enterocolitica gastroenteritis is best achieved through isolation of the bacterium on routine or selective bacteriologic media. When necessary, serogrouping, biogrouping, and assessment for plasmid-encoded virulence traits may aid in distinguishing virulent from "avirulent" strains. Epidemiologically, outside of identified food-borne outbreaks, the source (reservoir) of Y. enterocolitica in sporadic cases is speculative. Therefore, prevention and control measures are difficult to institute.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Preliminary Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food — Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2006–2017

            Despite ongoing food safety measures in the United States, foodborne illness continues to be a substantial health burden. The 10 U.S. sites of the Foodborne Diseases Active Surveillance Network (FoodNet)* monitor cases of laboratory-diagnosed infections caused by nine pathogens transmitted commonly through food. This report summarizes preliminary 2017 data and describes changes in incidence since 2006. In 2017, FoodNet reported 24,484 infections, 5,677 hospitalizations, and 122 deaths. Compared with 2014–2016, the 2017 incidence of infections with Campylobacter, Listeria, non-O157 Shiga toxin–producing Escherichia coli (STEC), Yersinia, Vibrio, and Cyclospora increased. The increased incidences of pathogens for which testing was previously limited might have resulted from the increased use and sensitivity of culture-independent diagnostic tests (CIDTs), which can improve incidence estimates ( 1 ). Compared with 2006–2008, the 2017 incidence of infections with Salmonella serotypes Typhimurium and Heidelberg decreased, and the incidence of serotypes Javiana, Infantis, and Thompson increased. New regulatory requirements that include enhanced testing of poultry products for Salmonella † might have contributed to the decreases. The incidence of STEC O157 infections during 2017 also decreased compared with 2006–2008, which parallels reductions in isolations from ground beef. § The declines in two Salmonella serotypes and STEC O157 infections provide supportive evidence that targeted control measures are effective. The marked increases in infections caused by some Salmonella serotypes provide an opportunity to investigate food and nonfood sources of infection and to design specific interventions. FoodNet conducts active, population-based surveillance for laboratory-diagnosed infections caused by Campylobacter, Cryptosporidium, Cyclospora, Listeria, Salmonella, STEC, Shigella, Vibrio, and Yersinia in 10 sites that account for approximately 15% of the U.S. population (an estimated 49 million persons in 2016). FoodNet is a collaboration among CDC, 10 state health departments, the U.S. Department of Agriculture’s Food Safety and Inspection Service (USDA-FSIS), and the Food and Drug Administration (FDA). Laboratory-diagnosed bacterial infections are defined as isolation of bacteria from a clinical specimen by culture or detection by a CIDT. CIDTs detect bacterial antigens, nucleic acid sequences, or, for STEC, Shiga toxin or Shiga toxin genes. ¶ A CIDT-positive–only bacterial infection is a positive CIDT result without culture confirmation. Listeria cases are defined as isolation of L. monocytogenes or detection by a CIDT from a normally sterile site or from placental or fetal tissue in the instance of miscarriage or stillbirth. Laboratory-diagnosed parasitic infections are defined as detection of the parasite from a clinical specimen. Hospitalizations and deaths within 7 days of specimen collection are attributed to the infection. Surveillance for physician-diagnosed postdiarrheal hemolytic uremic syndrome (HUS) is conducted through a network of nephrologists and infection preventionists and hospital discharge data review. This report includes pediatric HUS cases identified during 2016, the most recent year for which data are available. Incidence per 100,000 population was calculated by dividing the number of infections in 2017 by the U.S. Census estimates of the surveillance area population for 2016. Incidence measures include all laboratory-diagnosed infections reported. A negative binomial model with 95% confidence intervals (CIs) was used to estimate change in incidence during 2017 compared with that during 2014–2016 and 2006–2008. Because of large changes in testing practices since 2006, incidence comparisons with 2006–2008 used only culture-confirmed bacterial infections, and comparisons with 2014–2016 used culture-confirmed and CIDT-positive–only cases combined. For HUS, 2016 incidence was compared with that during 2013–2015. Cases of Infection, Incidence, and Trends During 2017, FoodNet identified 24,484 cases of infection, 5,677 hospitalizations, and 122 deaths. The incidence of infection per 100,000 population was highest for Campylobacter (19.2) and Salmonella (16.0), followed by Shigella (4.3), STEC (4.2),** Cryptosporidium (3.7), Yersinia (1.0), Vibrio (0.7), Listeria (0.3), and Cyclospora (0.3) (Table 1). The percentage of CIDT-positive–only infections, including those that were culture-negative and those not tested by culture, were Yersinia (51%), Campylobacter (36%), Shigella (31%), Vibrio (29%), STEC (27%), Salmonella (9%), and Listeria (1%) (Figure). Compared with incidence during 2014–2016, the 2017 incidence was significantly higher for Cyclospora (489% increase), Yersinia (166% increase), Vibrio (54% increase), STEC (28% increase), Listeria (26% increase), and Campylobacter (10% increase) (Table 1). Bacterial infections diagnosed by CIDT increased 96% overall (range = 34%–700% per pathogen) in 2017 compared with those diagnosed during 2014–2016. Reflex culture †† was attempted on 71% of CIDT-positive specimens, ranging from 63% for Campylobacter to 100% for Listeria (Figure). Among specimens on which a reflex culture was performed, the percentage of positive cultures ranged from 38% for Vibrio to 90% for Salmonella. TABLE 1 Incidence of bacterial and parasitic infections in 2017 and percentage change compared with 2014–2016 average annual incidence, by pathogen — FoodNet sites,* 2014–2017 † Pathogen 2017 2017 versus 2014–2016 No. of cases Incidence rate§ % Change¶ (95% CI) Bacteria Campylobacter 9,421 19.1 10 (2 to 18) Salmonella 7,895 16.0 -5 (-11 to 1) Shigella 2,132 4.3 -3 (-25 to 25) Shiga toxin–producing E. coli** 2,050 4.2 28 (9 to 50) Yersinia 489 1.0 166 (113 to 234) Vibrio 340 0.7 54 (26 to 87) Listeria 158 0.3 26 (2 to 55) Parasites Cryptosporidium 1,836 3.7 10 (-16 to 42) Cyclospora 163 0.3 489 (253 to 883) Abbreviations: CI = confidence interval; FoodNet = CDC’s Foodborne Diseases Active Surveillance Network. * Connecticut, Georgia, Maryland, Minnesota, New Mexico, Oregon, Tennessee, and selected counties in California, Colorado, and New York. † Data for 2017 are preliminary. § Per 100,000 population. ¶ Percentage change reported as increase or decrease. ** For Shiga toxin–producing E. coli, all serogroups were combined because it is not possible to distinguish between serogroups using culture-independent diagnostic tests. Reports that were only Shiga toxin–positive from clinical laboratories and were Shiga toxin–negative at a public health laboratory were excluded (n=518). When these were included, the incidence rate was 5.2, which was a 57% increase (CI = 33% to 85%). FIGURE Number of infections diagnosed by culture or culture-independent diagnostic tests, by pathogen, year, and culture status — FoodNet sites,* 2014–2017†,§ Abbreviations: CIDT = culture-independent diagnostic test; FoodNet = CDC’s Foodborne Diseases Active Surveillance Network; STEC = Shiga toxin–producing Escherichia coli. * Connecticut, Georgia, Maryland, Minnesota, New Mexico, Oregon, Tennessee, and selected counties in California, Colorado, and New York. † Data for 2017 are preliminary. § For STEC, all serogroups were combined because it is impossible to distinguish between serogroups using CIDTs. Reports that were only Shiga toxin–positive from clinical laboratories and were Shiga toxin–negative at a public health laboratory were excluded (n=518). The figure above consists of seven bar charts indicating the number of infections diagnosed by culture or culture-independent diagnostic tests by pathogen, year, and culture status from CDC’s Foodborne Diseases Active Surveillance Network (FoodNet) during 2014—2017. Among 6,373 (89%) fully serotyped Salmonella isolates, the five most common were Enteritidis (incidence = 2.6 per 100,000), Typhimurium (1.4), Newport (1.3), Javiana (1.1), and the monophasic variant of Typhimurium, I 4,[5],12:i:- (0.9) (Table 2). Among the 13 most common serotypes, the incidence for Heidelberg in 2017 was 65% lower than during 2006–2008 and 38% lower than during 2014–2016 (Table 2). It was also significantly lower for Typhimurium for both periods (42% and 14%, respectively). TABLE 2 Incidence of infection of the top 13 Salmonella serotypes in 2017 compared with 2006–2008 and 2014–2016 average annual incidence, by pathogen — FoodNet sites,* 2006–2017 † Serotype 2017 2017 versus 2006–2008 2017 versus 2014–2016 Incidence rate§ % Change¶ (95% CI) % Change¶ (95% CI) Enteritidis 2.6 3 (-11 to 20) -8 (-21 to 7) Typhimurium** 1.4 -42 (-48 to -34) -14 (-24 to -2) Newport 1.3 -5 (-22 to 16) -19 (-34 to -2) Javiana 1.1 99 (57 to 153) -7 (-26 to 17) I 4,[5],12:i:-** 0.9 35 (-5 to 74) 1 (-22 to 29) Muenchen 0.4 -13 (-35 to 14) -4 (-28 to 27) Infantis 0.3 60 (19 to 113) -20 (-39 to 6) Montevideo 0.3 -30 (-47 to -8) 24 (-7 to 66) Braenderup 0.3 29 (-5 to 76) 25 (-8 to 70) Saintpaul 0.3 -36 (-53 to -14) -20 (-40 to 9) Thompson 0.3 70 (22 to 138) 32 (-5 to 84) I 13,23:b:- †† 0.3 N/A N/A N/A N/A Heidelberg 0.2 -65 (-75 to -52) -38 (-55 to -15) Abbreviations: CI = confidence interval; FoodNet = CDC’s Foodborne Diseases Active Surveillance Network; N/A = not applicable. * Connecticut, Georgia, Maryland, Minnesota, New Mexico, Oregon, Tennessee, and selected counties in California, Colorado, and New York. † Data for 2017 are preliminary. § Per 100,000 population. ¶ Percentage change reported as increase or decrease. ** Percentage change (95% CI) for Typhimurium including monophasic variant (I, 4[5],12:i:-) compared with 2006–2008 and 2014–2016 was -26% (-34% to -17%) and -11% (-20% to 0%), respectively. †† Comparisons could not be calculated for serotype I 13,23,b:I because of sparse data across the entire period. Among 1,473 STEC isolates tested for the O157 antigen, 413 (28%) were determined to be O157. Among the 766 non-O157 STEC isolates with serogroup determined, the most common were O26 (29%), O103 (26%), and O111 (18%). During 2017, the incidence of non-O157 STEC significantly increased 25% (95% CI = 9–44) compared with that during 2014–2016; incidence of STEC O157 was unchanged. However, compared with 2006–2008, the incidence of STEC O157 was significantly lower (35% decrease; 95% CI = 21–46). FoodNet identified 57 cases of HUS in children (incidence = 0.51 per 100,000) during 2016; 35 (61%) occurred among children aged 50% in the percentage of broiler chicken samples that yielded Infantis from 2006 to 2017 (USDA-FSIS, unpublished data). The decreasing availability of STEC serogroup information, attributable to CIDTs, makes interpretation of trends difficult. However, the decreased incidence of HUS among young children during 2016 compared with that during 2006–2008 provides evidence that supports the finding of a decline in STEC O157 infections because most HUS cases are caused by STEC O157 ( 6 ). This decline also mirrors declines in STEC O157 in ground beef during the same period. CIDTs pose challenges to public health when reflex culture is not performed. Without isolates, public health laboratories are unable to subtype pathogens, determine antimicrobial susceptibility, and detect outbreaks. Reflex culture recovery rates vary, which could be attributed to false positives, low numbers of bacteria, storage or transport problems, or insensitive culture techniques ( 7 , 8 ). Furthermore, CIDTs vary in sensitivity and specificity. Evaluations of panel tests have indicated high sensitivity and specificity, differing by test type and manufacturer. The Association of Public Health Laboratories recommends that clinical laboratories culture CIDT-positive specimens ( 9 ). The lack of isolates for 25% of bacterial infections in 2017 is cause for concern. The findings in this report are subject to at least two limitations. First, the changing diagnostic landscape makes interpretation of incidence and trends difficult. In addition to actual increases in infection, increases in reported incidence might be due to some health care providers being more likely to order a CIDT because results are more quickly obtained than with traditional culture methods ( 1 ). Increases in incidence could also be due to increased use of DNA-based syndrome panel tests that diagnose pathogens not captured routinely by older methods. With improved sensitivity and specificity of DNA-based CIDTs, infections that previously would have remained undetected by culture methods might now be detected. Second, changes in incidence can reflect year-to-year variation rather than sustained trends. Most foodborne illnesses can be prevented. New regulatory requirements aimed at reducing contamination of poultry meat might have contributed to decreases in incidence of infections caused by Salmonella serotypes Typhimurium and Heidelberg. Vaccination might also have contributed, but the extent of vaccination in poultry broiler flocks has not been reported. The declines in these and in STEC O157 infections provide supportive evidence that targeted control measures are effective. More control measures are needed and might be achieved with continued implementation of the FDA Food Safety Modernization Act, §§ new or revised meat and poultry performance standards, and enhanced training and guidance for industry and inspection personnel. In particular, measures targeting specific Salmonella serotypes, including vaccination of broiler poultry flocks, might result in a marked decrease in human illness, as has been seen in the United Kingdom ( 10 ). Summary What is already known about this topic? The incidence of infections transmitted commonly through food has remained largely unchanged for many years. Culture-independent diagnostic tests (CIDTs) are increasingly used by clinical laboratories to detect enteric infections. CIDTs benefit public health surveillance by identifying illnesses caused by pathogens not captured routinely by previous laboratory methods. What is added by this report? Decreases in incidence of infection of Shiga toxin–producing Escherichia coli (STEC) O157 and Salmonella serotypes Typhimurium and Heidelberg have been observed over the past 10 years. These declines parallel findings of decreased Salmonella contamination of poultry meat and decreased STEC O157 contamination of ground beef. What are the implications for public health practice? As use of CIDTs continues to increase, higher, more accurate incidence rates might be observed. However, without isolates, public health laboratories are unable to subtype pathogens, determine antimicrobial susceptibility, and detect outbreaks. Further prevention measures are needed to decrease the incidence of infection by pathogens transmitted commonly through food.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Yersinia enterocolitica.

                Bookmark

                Author and article information

                Journal
                Open Forum Infect Dis
                Open Forum Infect Dis
                ofid
                Open Forum Infectious Diseases
                Oxford University Press (US )
                2328-8957
                April 2019
                05 March 2019
                05 March 2019
                : 6
                : 4
                : ofz116
                Affiliations
                [1 ]Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine
                [2 ]Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston
                Author notes
                Correspondence: Pablo C. Okhuysen, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1460, Houston, TX 77030 ( pcokhuysen@ 123456mdanderson.org ).
                Article
                ofz116
                10.1093/ofid/ofz116
                6488527
                02863bda-8348-46f1-99a0-fe222cc87d14
                © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence ( http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 03 January 2019
                : 01 March 2019
                Page count
                Pages: 5
                Funding
                Funded by: Maria Rodriguez-Barradas
                Categories
                Major Article

                gastrointestinal multiplex panel (gimp),immunocompromised host,molecular diagnostics,nucleic acid amplification testing (naat),yersinia enterocolitica

                Comments

                Comment on this article